XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Cash flows from operating activities:    
Net income $ 117,504 $ 23,232
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 85,811 37,355
Deferred income taxes (10,513) (54)
Amortization of deferred financing costs 6,164 17,600
Stock-based compensation 11,047 28,499
Loss on disposition of assets 132 68
Loss on extinguishment of debt 890
Consolidation, restructuring, and other noncash charges 318 2,378
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable 32,268 (5,929)
Inventory (62,771) (8,531)
Prepaid expenses and other current assets (12,166) (10,298)
Other noncurrent assets 7,369 (225)
Accounts payable (21,018) 34,215
Accrued expenses and other current liabilities (9,692) 6,003
Other noncurrent liabilities 4,805 8,223
Net cash provided by operating activities 149,258 133,426
Cash flows from investing activities:    
Capital expenditures (29,577) (21,761)
Proceeds from sale of assets 518 22
Purchase of marketable securities (29,982)
Proceeds from sale of marketable securities 120,483
Acquisition of business, net of cash acquired (2,908,241)
Purchase price adjustments for acquisition of business 27,466
Net cash used in investing activities (1,593) (2,839,479)
Cash flows from financing activities:    
Proceeds received from issuance of common stock 605,492
Proceeds received from issuance of preferred stock 445,319
Proceeds received from term loans, net of financing costs 1,286,230
Proceeds received from senior notes, net of financing costs 494,200
Finance fees paid in connection with credit facilities and senior notes (57) (20,000)
Repayments of term loans (230,000) (9,952)
Repayments of notes payable (364) (380)
Principal payments on finance lease obligations (3,196) (679)
Preferred stock dividends paid (17,250)
Exercise of stock options 10,395 17,717
Repurchase of common stock (6,559) (7,656)
Net cash provided by/(used in) financing activities (247,031) 2,810,291
Effect of exchange rate changes on cash (1,460) 179
Cash and cash equivalents:    
Increase/(Decrease) during the period (100,826) 104,417
Cash and cash equivalents, at beginning of period 182,862 151,086
Cash and cash equivalents, at end of period 82,036 255,503
Supplemental disclosures of cash flow information:    
Income taxes 47,694 12,405
Interest $ 54,940 $ 4,925